The growing interest in GLP-1 stems partly from the success of GLP-1 receptor agonist medications (such as semaglutide and liraglutide) in treating type 2 diabetes and obesity
Wood ER, Truesdale AT, McDonald OB, Yuan D, Hassell A, Dickerson SH, et al
doi: 10.1016/j.biomaterials.2013.04.064
Thyroid Monitoring While on GLP-1 Therapy Patients using semaglutide with a history of Graves' disease need more frequent thyroid function testing than standard GLP-1 users
Red flags to avoid rigid weekly-only assumptions fragmented tracking across separate screens no clean summary/export for appointments too many taps for basic daily actions These look minor at first and become fatal after week 4
At Slinic, we provide this through a clinician-led service that includes: Strict eligibility assessments based on the latest NICE guidelines